IL-6 inhibitors (Interprotein/RIKEN)

N/A

Report date: 2025/01/26 17:43:20
NME

Base Information

Drug NameIL-6 inhibitors (Interprotein/RIKEN)
Drug Alias Nameinterleukin-6 antagonist (Interprotein/Evotec)IL-6 inhibitors (Interprotein)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIL-6 receptor antagonists
TargetsIL-6 receptor
Therapy Area/IndicationsCachexiaInflammationCastleman Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInterprotein Corp
China Registration ClassN/A

Develop Information

Active CompaniesRikenInterprotein Corp
Inactive CompaniesEvotec SE
Active IndicationsCachexiaInflammationCastleman Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A